Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-20-136945
Filing Date
2020-12-18
Accepted
2020-12-17 17:36:40
Documents
1
Group Members
DENNISON T. VERU

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2038853d1_sc13da.htm SC 13D/A 37776
  Complete submission text file 0001104659-20-136945.txt   39410
Mailing Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401
Business Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401 972-2-5486555
Anchiano Therapeutics Ltd. (Subject) CIK: 0001534248 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86953 | Film No.: 201397226
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BRIDGE PLAZA, SUITE 695 FORT LEE NJ 07024
Business Address ONE BRIDGE PLAZA, SUITE 695 FORT LEE NJ 07024 201-585-7733
Palisade Medical Equity I, LP (Filed by) CIK: 0001702254 (see all company filings)

EIN.: 812229431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A